Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study.
Aged
Female
Graft Rejection
Humans
Hypertension, Pulmonary
/ mortality
Intention to Treat Analysis
Lung Diseases, Interstitial
/ mortality
Lung Transplantation
/ mortality
Male
Middle Aged
Pulmonary Disease, Chronic Obstructive
/ mortality
Retrospective Studies
Survival Analysis
Time Factors
Tissue and Organ Procurement
United States
/ epidemiology
Waiting Lists
chronic obstructive pulmonary disease
idiopathic pulmonary fibrosis
lung transplantation
Journal
Annals of the American Thoracic Society
ISSN: 2325-6621
Titre abrégé: Ann Am Thorac Soc
Pays: United States
ID NLM: 101600811
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
pubmed:
7
9
2018
medline:
16
4
2020
entrez:
7
9
2018
Statut:
ppublish
Résumé
Bilateral lung transplantation is widely used to treat chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD), on the basis of an expectation of improved survival after transplantation. Yet, waiting list mortality is higher while awaiting bilateral transplantation. The net effect of procedure preference on overall survival is unknown. To determine whether an unrestricted procedure preference is associated with improved overall outcomes after listing for lung transplantation. We performed a retrospective cohort study of 12,155 adults with COPD or ILD listed for lung transplantation in the United States between May 4, 2005, and December 31, 2014. We defined a "restricted" procedure preference as listing for "bilateral transplantation only" and an "unrestricted" procedure preference as listing for any combination of bilateral or single lung transplantation. We used a composite "intention-to-treat" primary outcome that included events both before and after transplantation, defined as the number of days between listing and death, removal from the list for clinical deterioration, or retransplantation. In adjusted analyses, an unrestricted procedure preference was associated with a 3% lower rate of the primary intention-to-treat outcome in COPD (adjusted hazard ratio [aHR], 0.97; 95% confidence interval [CI], 0.89-1.07) and a 1% higher rate in ILD (aHR, 1.01; 95% CI, 0.94-1.08). There was no convincing evidence that these associations varied by age, disease severity, or the use of mechanical support. Among those with ILD and concomitant severe pulmonary hypertension, an unrestricted preference was associated with a 17% increased rate of the primary outcome (aHR, 1.17; 95% CI, 0.99-1.39). An unrestricted preference was consistently associated with lower rates of death or removal from the list for clinical deterioration and with higher rates of transplantation. Graft failure rates were similar among those listed with restricted and unrestricted preferences. When considering outcomes both before and after transplantation, we found no evidence that patients with COPD or ILD benefit from listing for bilateral lung transplantation compared with listing for a more liberal procedure preference. An unrestricted listing strategy for suitable candidates may increase the number of transplants performed without impacting overall survival.
Identifiants
pubmed: 30188172
doi: 10.1513/AnnalsATS.201804-258OC
pmc: PMC6376945
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-239Subventions
Organisme : NHLBI NIH HHS
ID : K24 HL131937
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL114626
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL105323
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Lancet. 2007 Sep 1;370(9589):765-73
pubmed: 17765526
Am J Respir Crit Care Med. 2011 Dec 1;184(11):1282-8
pubmed: 21868502
N Engl J Med. 2011 Apr 14;364(15):1431-40
pubmed: 21488765
J Heart Lung Transplant. 2016 May;35(5):657-60
pubmed: 26856664
Stat Med. 1983 Apr-Jun;2(2):267-71
pubmed: 6648141
Am J Surg. 2013 Apr;205(4):381-6
pubmed: 23414636
Eur Respir Rev. 2012 Dec 1;21(126):355-61
pubmed: 23204124
J Heart Lung Transplant. 2010 Oct;29(10):1165-71
pubmed: 20598580
Transpl Int. 2015 Feb;28(2):170-9
pubmed: 25266074
J Thorac Dis. 2014 Aug;6(8):1032-8
pubmed: 25132970
Transpl Int. 2010 Jun;23(6):628-35
pubmed: 20059752
World J Transplant. 2016 Jun 24;6(2):347-55
pubmed: 27358780
Transplantation. 2011 Apr 27;91(8):921-6
pubmed: 21343871
Am J Respir Crit Care Med. 2006 Sep 15;174(6):710-6
pubmed: 16799075
Fed Regist. 2007 Mar 30;72(61):15197-280
pubmed: 17450666
Lancet. 2008 Mar 1;371(9614):744-51
pubmed: 18313503
Am J Transplant. 2018 Jan;18(1):226-231
pubmed: 28862792
Ann Intern Med. 2017 Aug 15;167(4):268-274
pubmed: 28693043
Epidemiology. 2018 Jan;29(1):e5-e6
pubmed: 28901974
Interact Cardiovasc Thorac Surg. 2012 Mar;14(3):263-7
pubmed: 22180607
Am J Transplant. 2018 Jan;18 Suppl 1:363-433
pubmed: 29292602
Ann Thorac Surg. 2009 Nov;88(5):1616-25; discussion 1625-6
pubmed: 19853121
Transplantation. 2014 Oct 27;98(8):903-8
pubmed: 24825527
Ann Intern Med. 2009 Dec 1;151(11):767-74
pubmed: 19949142
JAMA. 2015 Mar 3;313(9):936-48
pubmed: 25734735